Get startedLog in
    Picture of Resonance Health logo

    RHT — Resonance Health News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$6.33 Million Over 18 Months

    Picture of Resonance Health logoResonance Health
    18/08/2023 02:19
    Aug 18 (Reuters) - Resonance Health Ltd  RHT.AX :
    * CONTRACTED BY SUN PHARMACEUTICAL INDUSTRIES
    * CONTRACTED FOR CLINICAL DRUG TRIAL WORTH A$6.33 MILLION
OVER 18
MONTHS
    * RESONANCE WILL PROVIDE ITS IMAGING ANALYSIS SERVICES AT
VARIOUS
TIMEPOINTS THROUGHOUT CLINICAL TRIAL, AMONG OTHERS

Source text for Eikon:  ID:nASX7TGbc2 
Further company coverage:  RHT.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Resonance Health

    See all news